As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with ...

Summit Therapeutics shows promising results in Phase III trials for ivonescimab as a potential treatment for advanced NSCLC.

Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...

Investigators were seeking clarification on optimal sequencing of the immune checkpoint inhibitor atezolizumab following ...

The discovery of new biomarkers, drug targets, and therapeutic mechanisms is pivotal for the development of effective treatments across a spectrum of diseases. Traditional methods, such as omics ...

After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ ...

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial ...

Come Jan. 1, Centerlight CHHA, one of the largest home health agencies in New York, New York, will be known as Cassena Care ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

Alice L. Walton School of Medicine (AWSOM) recently announced the hiring of four key faculty members including Chelsey Deel, ...

"It is important to note that this study reports associations between beta-blocker use in patients ... "However, these ...

It's Seasonal Depression Awareness Month — and therapists are clearing up myths about what it means to have SAD.